share_log
Breakings ·  Dec 16 21:05
Tharimmune: Plan to Report Preliminary Results From Phase 2 Trial in Late 2025
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment